Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

AIRMA announces 2007 research grant recipients

08.05.2007
The Association Internationale pour la Recherche sur la Maladie d’Alzheimer (AIRMA) today selected the recipients for its 2007 research grant program, announced Janet R. Michaels, the nonprofit organization’s chairwoman.

Research projects to be funded will further clarify the roles of amyloid precursor protein (APP) metabolites, which regulate stem cells in the brain, as well as nutrition’s possible impact on the development of Alzheimer’s disease. The France-based Alzheimer’s research association also will provide funds to the INSERM Unit 837 Brain Bank.

With these newest grants, AIRMA has provided near 500,000 euros in grants to France-based research institutions since 2003.

Dr. Bernadette Allinquant, research team manager at INSERM Unit 573 in the Centre Paul Broca in Paris, and Dr. Pascale Barberger-Gateau of INSERM Bordeaux, were selected through a rigorous grant-application and review process.

... more about:
»Alzheimer »Inserm

“AIRMA is thrilled to provide these grants to advance valuable research into risk factors and causes of Alzheimer’s disease,” Michaels said. “Our main purpose is to provide funds to promising research so we can shed light on and hopefully find a cure for Alzheimer’s.”

Dr. Allinquant’s research (“Mechanisms of neurostimulating properties of sAPP”) focuses on the function of the sAPP metabolite molecule and its putative role in protection - - of Alzheimer’s. Currently, the molecule’s function is not fully understood. In France, Dr. Allinquant, who holds doctoral degrees in biochemistry and neurochemistry, is a well-regarded researcher of Alzheimer’s, aging and neuro-developmental disorders, focusing on molecular and cell biology.

Dr. Barberger-Gateau, a senior lecturer at Bordeaux University, is researching the correlation between the presence of Vitamin A in the body and risk for Alzheimer’s disease (“Fatty acids, retinoids and Alzheimer’s Disease”). She has published various articles on the epidemiology of nutrition and food behavior in various international scientific journals.

The grantees were selected from among a highly deserving field of applicants through a stringent review and qualification process. The research teams were judged on a multitude of factors, including importance of the problem being researched, level of innovation and the capability of the researcher.

In addition to the 2007 grants, AIRMA also is providing funding to the INSERM Unit 837 (Lille, France) Brain Bank directed by Dr. André Delacourte. The Brain Bank is one of the premier brain banks in Europe, housing hundreds of specimens of brains affected by Alzheimer’s and other types of dementia. Research conducted at the Brain Bank has helped discover and explain the 10-stage evolution of Alzheimer’s disease. This crucial research has been threatened by a lack of funding.

Dr. Delacourte is a noted biologist specializing in Alzheimer’s disease. He has studied neuro-degenerative diseases for more than 30 years. He is a unit research director at INSERM, the French Institute of Health and Medical Research, and heading up a team researching Alzheimer's disease.

More than 225,000 people are affected by Alzheimer’s in France each year. The age-related degenerative disease exerts a toll on the patient, the family and the French health system. In latter stages, Alzheimer’s patients require round-the-clock care.

Celine Torres | alfa
Further information:
http://www.airma.org

Further reports about: Alzheimer Inserm

More articles from Life Sciences:

nachricht Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University

nachricht How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>